Q&A With Ludwig Kappos From University of Basel: Further Research Provides Positive Answers For Lingering Aubagio Questions


Recent research suggests that treatment with teriflunomide may slow brain atrophy in patients with relapsing multiple sclerosis.

With a condition as complicated as multiple sclerosis there are always going to be questions that need to be answered when it comes to patient care. One recent area of interest is preventing brain atrophy in this particular patient population.

Ludwig Kappos, MD, from the University of Basel in Switzerland discussed the results of this latest round of testing and what further tests could be conducted during the annual ECTRIMS congress in Barcelona.

Recent Videos
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
Stephanie Nahas, MD, MSEd | Credit: Jefferson Health
John Harsh, PhD: Exploring Once-Nightly Sodium Oxybate Therapy for Narcolepsy
John Harsh, PhD
© 2024 MJH Life Sciences

All rights reserved.